A study has found that under-the-tongue drops are more efficient treatment options than shots in treating allergies.
Patients allergic to pollen or grass are required to take weekly injections for many years. Doses containing the allergen are given to strengthen the immunity of the patients to those allergens.
Allergy - Symptom Evaluation
An allergic reaction may be mild or severe. It usually involves the skin, respiratory system, eyes, digestive system or blood pressure.
Advertisement
Dr. Sandra Lin at Johns Hopkins University analyzed 63 previous studies, which evaluated the efficacy of sublingual drops in treating allergies. Allergy drops are widely used in Europe and as an off-label drug in USA. FDA has not yet approved the drops therapy in US.
Based on the review it was found that the drops reduced the allergy symptoms by more than 40% when compared with other treatment options like injections.
The author opines that this is an attractive option for many especially kids who are reluctant to take shots.
The report is published online Wednesday in the Journal of the American Medical Association.
Source: Medindia
The author opines that this is an attractive option for many especially kids who are reluctant to take shots.
The report is published online Wednesday in the Journal of the American Medical Association.
Source: Medindia
Advertisement
 Life Saving Treatment for Fire Ant Allergy Under Used: StudyTwo million Americans are allergic to insect sting. It is an allergy which sends more than 500,000 people to the emergency room annually. | Advertisement
|
Vitamin D Levels of Mother During Pregnancy Linked to Allergy Risk in Offspring
A child's risk of developing allergies could depend on the vitamin D levels of the mother during her pregnancy, according to a new study.
Advertisement
Recommended Readings
Latest Research News
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.